Sign up Australia
Proactive Investors - Run By Investors For Investors

Pharmaxis' CEO Gary Phillips updates on partnership with Boehringer Ingelheim

Pharmaxis will receive €10 million milestone payment when the first patient is dosed in this 2nd indication Phase IIa study.

 
Meet Premier African Minerals Ltd, Anglo Asian Mining Plc and Thor Mining PLC at our event, London, 21 September 2017. Register here »


Register here to be notified of future Pharmaxis Ltd articles
View full PXS profile View Profile

Pharmaxis Ltd Timeline

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use